Metastasis is a significant contributor to morbidity and mortality for many cancer patients and
remains a major obstacle for effective treatment. In many tissue types, metastasis is fueled …

The epithelial-mesenchymal transition (EMT) is a key process implicated in cancer metastasis
and therapy resistance. Recent studies have emphasized that cells can undergo partial …

These findings present inhibition of spleen tyrosine kinase as a therapeutic option to limit
breast cancer metastasis by promoting systemic tumor dormancy. See related commentary by …

The Epithelial–mesenchymal transition (EMT) is a cellular process implicated in embryonic
development, wound healing, and pathological conditions such as cancer metastasis and …

Thermoresponsive poly(N-isopropylacrylamide) (PNIPAAm) hydrogels are widely studied
smart materials, particularly for biomedical applications, but are limited by their mechanical …

These findings confirm the fidelity and sensitivity of the EMT lineage tracing (Tri-PyMT)
model and highlight the differential contributions of pre- and post-EMT tumor cells in breast …

Aberrant activation of epithelial-mesenchymal transition (EMT) in carcinoma cells
contributes to increased migration and invasion, metastasis, drug resistance, and tumor-initiating …

Tumor microenvironments contain multiple cell types interacting among one another via
different signaling pathways. Furthermore, both cancer cells and different immune cells can …

… All data were analyzed for statistically significant differences using the Student t test (for
two comparisons) or ANOVA with Tukey post hoc correction (for multiple comparisons) in JMP …

Epithelial–mesenchymal transition (EMT) and its reverse mesenchymal–epithelial transition
(MET) are critical during embryonic development, wound healing and cancer metastasis. …